Stereotactic body radiation therapy (SBRT) for lung malignancies: Preliminary toxicity results using a flattening filter-free linear accelerator operating at 2400 monitor units per minute

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Prendergast, Brendan M ^a   Dobelbower, Michael C ^b   Bonner, James A ^b   Popple, Richard A ^b   Baden, Craig J ^b   Minnich, Douglas J ^c   Cerfolio, Robert J ^c   Spencer, Sharon A ^b   Fiveash, John B ^b  

^a Space Coast Cancer Center ^*  (United States)

^b The University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Flattening filter free (FFF); Lung cancer; SBRT; Toxicity

Indexed keywords

ACUTE TOXICITY; ADULT; ARTICLE; ATELECTASIS; CARDIOTOXICITY; CLINICAL ASSESSMENT; DOSE RESPONSE; EFFUSION; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LINEAR ACCELERATOR; MAJOR CLINICAL STUDY; MALE; MONITOR; PHOTON; PNEUMONIA; RADIATION DOSE; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; TUMOR VOLUME; COMPUTER ASSISTED RADIOTHERAPY; EQUIPMENT; LUNG; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MAGNETIC AND ELECTROMAGNETIC EQUIPMENT; METASTASIS; METHODOLOGY; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOSURGERY; RISK; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LOGISTIC MODELS; LUNG; LUNG NEOPLASMS; NEOPLASM METASTASIS; PARTICLE ACCELERATORS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; RISK; TIME FACTORS; TREATMENT OUTCOME;

EID: 84887792305     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-273     Document Type: Article

References (26)

1. Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gaspar LE, Schefter TE. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009, 27:1579-1584. 10.1200/JCO.2008.19.6386, 19255320.
2. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303:1070-1076. 10.1001/jama.2010.261, 2907644, 20233825.
3. Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C, Williams M, Fletcher J. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006, 24:4833-4839. 10.1200/JCO.2006.07.5937, 17050868.
4. Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, Sakamoto M, Mitsumori M, Shibuya K, Araki N, Yano S, Hiraoka M. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63:1427-1431. 10.1016/j.ijrobp.2005.05.034, 16169670.
5. RTOG 0236: A phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I/II non-small cell lung cancer. [http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0236].
6. RTOG 0813: Seamless Phase I/II Study of Stereotactic Lung Radiotherapy (SBRT) for Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) in Medically Inoperable Patients. [http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0813].
7. Purdie TG, Bissonnette JP, Franks K, Bezjak A, Payne D, Sie F, Sharpe MB, Jaffray DA. Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: localization, verification, and intrafraction tumor position. Int J Radiat Oncol Biol Phys 2007, 68:243-252. 10.1016/j.ijrobp.2006.12.022, 17331671.
8. Stathakis S, Esquivel C, Gutierrez A, Buckey CR, Papanikolaou N. Treatment planning and delivery of IMRT using 6 and 18MV photon beams without flattening filter. Appl Radiat Isot 2009, 67:1629-1637. 10.1016/j.apradiso.2009.03.014, 19369083.
9. Vassiliev ON, Kry SF, Chang JY, Balter PA, Titt U, Mohan R. Stereotactic radiotherapy for lung cancer using a flattening filter-free Clinac. J Appl Clin Med Phys 2009, 10:2880.
10. Cashmore J. The characterization of unflattened photon beams from a 6 MV linear accelerator. Phys Med Biol 2008, 53:1933-1946. 10.1088/0031-9155/53/7/009, 18364548.
11. Zhang GG, Ku L, Dilling TJ, Stevens CW, Zhang RR, Li W, Feygelman V. Volumetric modulated arc planning for lung stereotactic body radiotherapy using conventional and unflattened photon beams: a dosimetric comparison with 3D technique. Radiat Oncol 2011, 6:152. 10.1186/1748-717X-6-152, 3354344, 22070866.
12. Scorsetti M, Alongi F, Castiglioni S, Clivio A, Fogliata A, Lobefalo F, Mancosu P, Navarria P, Palumbo V, Pellegrini C, Pentimalli S, Reggiori G, Ascolese AM, Roggio A, Arcangeli S, Tozzi A, Vanetti E, Cozzi L. Feasibility and early clinical assessment of flattening filter-free (FFF) based stereotactic body radiotherapy (SBRT) treatments. Radiat Oncol 2011, 6:113. 10.1186/1748-717X-6-113, 3179946, 21910868.
13. Prendergast BM, Popple RA, Clark GM, Spencer SA, Guthrie B, Markert J, Fiveash JB. Improved clinical efficiency in CNS stereotactic radiosurgery using a flattening filter-free linear accelerator. J Radiosurg SBRT 2011, 1:117-122.
14. Prendergast BM, Fiveash JB, Popple RA, Clark GM, Thomas EM, Minnich DJ, Jacob R, Spencer SA, Bonner JA, Dobelbower MC. Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapy. J Appl Clin Med Phys 2013, 14:4126.
15. National Cancer Institute Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events, Version 4.0 http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm. Accessed August 2, 2012, National Cancer Institute.
16. Rowe BP, Boffa DJ, Wilson LD, Kim AW, Detterbeck FC, Decker RH. Stereotactic body radiotherapy for central lung tumors. J Thorac Oncol in press.
17. Shibamoto Y, Hashizume C, Baba F, Ayakawa S, Manabe Y, Nagai A, Miyakawa A, Murai T, Iwata H, Mori Y, Mimura M, Ishikura S. Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study. Cancer 2012, 118:2078-2084. 10.1002/cncr.26470, 22009495.
18. Hall EJ, Giaccia AJ. Radiobiology for the Radiologist 2006, Philadelphia: Lippincott, Williams, and Wilkins.
19. Lohse I, Lang S, Hrbacek J, Scheidegger S, Bodis S, Macedo NS, Feng J, Lütolf UM, Zaugg K. Effect of high dose per pulse flattening filter-free beams on cancer cell survival. Radiother Oncol 2011, 101(1):226-232. 10.1016/j.radonc.2011.05.072, 21733592.
20. Verbakel WF, van den Berg J, Slotman BJ, Sminia P. Comparable cell survival between high dose rate flattening filter-free and conventional dose rate irradiation. Acta Oncol 2012, Epub ahead of print.
21. Sørensen BS, Vestergaard A, Overgaard J, Præstegaard LH. Dependence of cell survival on instantaneous dose rate of a linear accelerator. Radiother Oncol 2011, 101:223-225. 10.1016/j.radonc.2011.06.018, 21737168.
22. Ling CC, Gerweck LE, Zaider M, Yorke E. Dose-rate effects in external beam radiotherapy redux. Radiother Oncol 2010, 95:261-268. 10.1016/j.radonc.2010.03.014, 20363041.
23. Corradetti MN, Haas AR, Rengan R. Central-airway necrosis after stereotactic body-radiation therapy. N Engl J Med 2012, 366:2327-2329. 10.1056/NEJMc1203770, 22694017.
24. Kragl G, Baier F, Lutz S, Albrich D, Dalaryd M, Kroupa B, Wiezorek T, Knöös T, Georg D. Flattening filter-free beams in SBRT and IMRT: dosimetric assessment of peripheral doses. Z Med Phys 2011, 21:91-101. 10.1016/j.zemedi.2010.07.003, 20888199.
25. Kry SF, Titt U, Pönisch F, Vassiliev ON, Salehpour M, Gillin M, Mohan R. Reduced neutron production through use of a flattening-filter-free accelerator. Int J Radiat Oncol Biol Phys 2007, 68:1260-1264. 10.1016/j.ijrobp.2007.04.002, 17637397.
26. Cashmore J, Ramtohul M, Ford D. Lowering whole-body radiation doses in pediatric intensity-modulated radiotherapy through the use of unflattened photon beams. Int J Radiat Oncol Biol Phys 2011, 80:1220-1227. 10.1016/j.ijrobp.2010.10.002, 21167659.